|
|
P Carmeliet, L Moons, V Ploplis, E Plow, D Collen
J Clin Invest. 1997;
99(2):200
doi:10.1172/JCI119148
Abstract |
Full text
| PDF

T
o define the role of plasminogen (Plg) in the smooth muscle cell response after arterial wall injury, neointima formation was evaluated after electric injury of the femoral artery in plasminogen-deficient (Plg-/-) mice. The injury destroyed all medial smooth muscle cells, denuded the injured segment of intact endothelium, and induced transient platelet-rich mural thrombosis. In wild-type (Plg+/+) mice, vascular wound healing was characterized by lysis of the thrombus, transient infiltration of inflammatory cells, and progressive removal of necrotic debris and thrombosis. Topographic analysis revealed repopulation of the media and accumulation in the neointima of smooth muscle cells originating from the noninjured borders, which progressed into the necrotic center. In Plg-/- mice, wound healing was significantly impaired with delayed removal of necrotic debris, reduced leucocyte infiltration and smooth muscle cell accumulation, and decreased neointima formation. Smooth muscle cells accumulated at the uninjured borders, but failed to migrate into the necrotic center. Proliferation of smooth muscle cells was not affected by Plg deficiency. Evans blue staining revealed no genotypic differences in reendothelialization. Thus, Plg plays a significant role in vascular wound healing and arterial neointima formation after injury, most likely by affecting cellular migration.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(47)
| Title and authors |
Publication |
Year |
Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration
Tatiana Lebedeva, Robin Wait, Grigory Ryzhakov, Yelena Parfyonova, Alexander Kapustin, Victoria Stepanova, Natalia Aniol, Douglas B. Cines, Alexei Poliakov, Serge Yarovoi
|
Biochem. J.
|
2012 |
The role of fibrinolytic genes and proteins in the development of allograft vascular disease
Raymond L. Benza, Michael J. Passineau, Peter G. Anderson, Joseph P. Barchue, James F. George
|
The Journal of Heart and Lung Transplantation
|
2011 |
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis
Henning W. Zimmermann, Alexander Koch, Sebastian Seidler, Christian Trautwein, Frank Tacke
|
Liver International
|
2011 |
Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activatorThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 2 of a 2-part Special Issue).
Vsevolod A. Tkachuk, Olga S. Plekhanova, Yelena V. Parfyonova
|
Can. J. Physiol. Pharmacol.
|
2009 |
Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism
Andrew M. Bakken, Clinton D. Protack, Elisa Roztocil, Suzanne M. Nicholl, Mark G. Davies
|
Journal of Vascular Surgery
|
2009 |
Patterns of gelatinase activation induced by injury in the murine femoral artery.
Yiping Zou, Yan Qi, Elisa Roztocil, Mark G Davies
|
J. Surg. Res.
|
2009 |
Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
Michal Kremen, Ranjini Krishnan, Isaac Emery, Jie Hong Hu, Katherine I Slezicki, Alyssa Wu, Kun Qian, Liang Du, Abigail Plawman, April Stempien-Otero, David A Dichek
|
Proc. Natl. Acad. Sci. U.S.A.
|
2008 |
Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis.
A A Higazi, M El-Haj, A Melhem, A Horani, O Pappo, C E Alvarez, N Muhanna, S L Friedman, R Safadi
|
Clin Exp Immunol
|
2008 |
Impact of plasminogen on an in vitro wound healing model based on a perfusion cell culture system
Moyuru Hayashi, Yuichi Matsuzaki, Motoyuki Shimonaka
|
Mol Cell Biochem
|
2008 |
Plasminogen activator/plasmin system in arthritis and inflammation: Friend or foe?
John A. Hamilton
|
Arthritis Rheum
|
2008 |
|